rs6080699
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002594.5(PCSK2):c.886-101G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.338 in 1,286,676 control chromosomes in the GnomAD database, including 78,789 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.26 ( 6489 hom., cov: 33)
Exomes 𝑓: 0.35 ( 72300 hom. )
Consequence
PCSK2
NM_002594.5 intron
NM_002594.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.977
Publications
3 publications found
Genes affected
PCSK2 (HGNC:8744): (proprotein convertase subtilisin/kexin type 2) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The protein undergoes an initial autocatalytic processing event and interacts with a neuroendocrine secretory protein in the ER, exits the ER and sorts to secretory granules, where it is cleaved and catalytically activated during intracellular transport. The encoded protease is packaged into and activated in dense core secretory granules and expressed in the neuroendocrine system and brain. This gene encodes one of the seven basic amino acid-specific members which cleave their substrates at single or paired basic residues. It functions in the proteolytic activation of polypeptide hormones and neuropeptides precursors. Single nucleotide polymorphisms in this gene may increase susceptibility to myocardial infarction and type 2 diabetes. This gene may also play a role in tumor development and progression. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.459 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PCSK2 | NM_002594.5 | c.886-101G>C | intron_variant | Intron 8 of 11 | ENST00000262545.7 | NP_002585.2 | ||
| PCSK2 | NM_001201528.2 | c.829-101G>C | intron_variant | Intron 9 of 12 | NP_001188457.1 | |||
| PCSK2 | NM_001201529.3 | c.781-101G>C | intron_variant | Intron 7 of 10 | NP_001188458.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PCSK2 | ENST00000262545.7 | c.886-101G>C | intron_variant | Intron 8 of 11 | 1 | NM_002594.5 | ENSP00000262545.2 | |||
| PCSK2 | ENST00000377899.5 | c.829-101G>C | intron_variant | Intron 9 of 12 | 1 | ENSP00000367131.1 | ||||
| PCSK2 | ENST00000536609.1 | c.781-101G>C | intron_variant | Intron 7 of 10 | 2 | ENSP00000437458.1 |
Frequencies
GnomAD3 genomes AF: 0.261 AC: 39694AN: 152038Hom.: 6492 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
39694
AN:
152038
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.349 AC: 395657AN: 1134520Hom.: 72300 AF XY: 0.354 AC XY: 201718AN XY: 569658 show subpopulations
GnomAD4 exome
AF:
AC:
395657
AN:
1134520
Hom.:
AF XY:
AC XY:
201718
AN XY:
569658
show subpopulations
African (AFR)
AF:
AC:
1438
AN:
26870
American (AMR)
AF:
AC:
8630
AN:
34798
Ashkenazi Jewish (ASJ)
AF:
AC:
5462
AN:
21568
East Asian (EAS)
AF:
AC:
10605
AN:
36654
South Asian (SAS)
AF:
AC:
35128
AN:
72414
European-Finnish (FIN)
AF:
AC:
11961
AN:
36546
Middle Eastern (MID)
AF:
AC:
1049
AN:
3758
European-Non Finnish (NFE)
AF:
AC:
305359
AN:
853014
Other (OTH)
AF:
AC:
16025
AN:
48898
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
12545
25090
37635
50180
62725
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
8964
17928
26892
35856
44820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.261 AC: 39678AN: 152156Hom.: 6489 Cov.: 33 AF XY: 0.264 AC XY: 19674AN XY: 74382 show subpopulations
GnomAD4 genome
AF:
AC:
39678
AN:
152156
Hom.:
Cov.:
33
AF XY:
AC XY:
19674
AN XY:
74382
show subpopulations
African (AFR)
AF:
AC:
2466
AN:
41544
American (AMR)
AF:
AC:
3935
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
904
AN:
3468
East Asian (EAS)
AF:
AC:
1557
AN:
5172
South Asian (SAS)
AF:
AC:
2292
AN:
4826
European-Finnish (FIN)
AF:
AC:
3407
AN:
10580
Middle Eastern (MID)
AF:
AC:
80
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24128
AN:
67962
Other (OTH)
AF:
AC:
615
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1441
2883
4324
5766
7207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
418
836
1254
1672
2090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1147
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.